IRCT20200506047323N4招募中2 期
Evaluation of the effects of Desferal on clinical symptoms in patients with COVID-19
Bandare-abbas University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- All
入选标准
- •Age >18 years
- •Positive polymerase chain reaction (PCR) test for COVID-19
- •Primary clinical symptoms
- •Hospitalized and moderate patients
- •Signing informed consent and willingness of study participant to accept randomization to any assigned treatment arm
排除标准
- •Underlying diseases, including renal failure (serum creatinine >2), myocarditis and arrhythmia, anemia (hemoglobin<4-8), lower respiratory tract infection, and asthma
- •Patients requiring intubation or frequent use of respiratory drugs
- •Severe and critical patients
- •History of allergy to studied drug
- •Pregnancy and breastfeeding
研究者
相似试验
招募中
2 期
Evaluation of safety and efficacy of Desferal + Zinc nasal spraycovid19.COVID19, virus identifiedU07.1IRCT20210519051348N1Shiraz University of Medical Sciences60
已完成
2 期
Deferiprone for the Treatment of Parkinson’s DiseaseEarly-stage Parkinson’s diseaseNeurological - Parkinson's diseaseACTRN12617001578392ApoPharma Inc.36
尚未招募
不适用
Clinical investigation of the effectiveness of different mouth rinses in Covid-19-PatientsCOVID-19DRKS00023725niversität Witten/Herdecke Fakultät für Gesundheit (Department für Zahn-, Mund- und Kieferheilkunde)Lehrstuhl für Zahnerhaltung und Präventive Zahnmedizin60
招募中
3 期
Effect of Deferiprone on the improvement of symptoms of Coronavirus 2019 (COVID 19)Patients with Covid 19.Covid 19U07.01IRCT20180114038350N3Sanandaj University of Medical Sciences80
招募中
2 期
Comparison of the efficacy and side effects of desloratadine with fexofenadine on allergic rhinitis in patients referred to Masih Daneshvari HospitalAllergic rhinitis.Allergic rhinitis due to pollenJ30.1IRCT20160516027929N11Shahid Beheshti University of Medical Sciences65